Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 3, 2015
Pharmacy Choice - Pharmacy News - August 3, 2015

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
8/2/15 - Finacea(R) (azelaic acid) Foam 15%, Approved by U.S. FDA for Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea [Saudi Press Agency (Saudi Arabia)]
-As announced today by Bayer HealthCare, the U.S. Food& Drug Administration has approved Finacea ® Foam, 15% for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. Finacea ® Foam was developed as part of a research and development collaboration between Foamix Pharmaceuticals Ltd. and Bayer HealthCare, utilizin
8/2/15 - Galderma Receives FDA Approval for New Antibiotic-Free Treatment Option for Acne Patients
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA-- Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration approved antibiotic-free Epiduo ® Forte Gel, 0.3%/ 2.5%, for the once-daily, topical treatment of acne vulgaris. Acne is the most common skin condition in the United States, affecting more than 4
8/2/15 - Germany : FDA Approves Bayer's Finacea (azelaic acid) Foam for the Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate... [TendersInfo (India)]
Germany: FDA Approves Bayer's Finacea Foam for the Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea. Bayer HealthCare today announced that the U.S. Food and Drug Administration has approved Finacea ® Foam, 15% for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
8/2/15 - Juno Announces FDA Clearance of Investigational New Drug Application for JCAR015 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia [Cihan News Agency (Turkey)]
-Juno Therapeutics, Inc., a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, today announced the U.S. Food and Drug Administration cleared the Company's investigational new drug application for JCAR015 for treatment of adult patients with relapsed/refractory acute lymphoblastic...
8/1/15 - Juno Announces FDA Clearance of Investigational New Drug Application for JCAR015 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia [Jerusalem Post (Israel)]
-Juno Therapeutics, Inc., a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, today announced the U.S. Food and Drug Administration cleared the Company's investigational new drug application for JCAR015 for treatment of adult patients with relapsed/refractory acute lymphoblastic...
8/1/15 - United States : FDA Grants Corvida Medical Clearance on Halo [TendersInfo (India)]
Emerging medical device firm Corvida Medical has received a 510 clearance from the US Food and Drug Administration to market its first product, the Halo Closed System Transfer Device, to protect health care professionals from exposure to hazardous drugs. The device received an ONB product code classification from the FDA, demonstrating no escape of

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415